Jasper Therapeutics Company Insiders

JSPR Stock  USD 22.47  0.16  0.72%   
Slightly above 75% of Jasper Therapeutics' corporate insiders are selling. The analysis of the overall insider sentiment regarding Jasper Therapeutics suggests that many insiders are alarmed. Jasper Therapeutics employs about 45 people. The company is managed by 14 executives with a total tenure of roughly 105 years, averaging almost 7.0 years of service per executive, having 3.21 employees per reported executive.

Jasper Therapeutics' Insider Buying Vs Selling

25

 
Selling
 
Buying

Latest Trades

2024-09-12Jeetinder Singh MahalDisposed 900 @ 21.23View
2024-06-12Jeetinder Singh MahalDisposed 900 @ 24.16View
2024-03-12Jeetinder Singh MahalDisposed 900 @ 26.44View
2024-02-08Velan Capital Investment ManagAcquired 350000 @ 12.95View
Monitoring Jasper Therapeutics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

Jasper Therapeutics' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Jasper Therapeutics' future performance. Based on our forecasts, it is anticipated that Jasper will maintain a workforce of slightly above 50 employees by January 2025.
 
Covid

Jasper Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.4092) % which means that it has lost $0.4092 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7146) %, meaning that it created substantial loss on money invested by shareholders. Jasper Therapeutics' management efficiency ratios could be used to measure how well Jasper Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/11/2024, Return On Tangible Assets is likely to drop to -0.71. In addition to that, Return On Capital Employed is likely to drop to -0.88. At this time, Jasper Therapeutics' Net Tangible Assets are relatively stable compared to the past year. As of 12/11/2024, Other Current Assets is likely to grow to about 1.9 M, while Total Assets are likely to drop slightly above 63.2 M.
As of 12/11/2024, Common Stock Shares Outstanding is likely to grow to about 11 M, though Net Loss is likely to grow to (32.2 M).

Jasper Therapeutics Workforce Comparison

Jasper Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,404. Jasper Therapeutics holds roughly 45.0 in number of employees claiming about 3% of equities under Health Care industry.

Jasper Therapeutics Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Jasper Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Jasper Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Jasper Therapeutics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
2.0
2
1
 1,800 
 900.00 
2024-06-01
13.0
13
1
 99,700 
 900.00 
2024-03-01
8.0
8
1
 766,800 
 900.00 
2023-12-01
2.0
6
3
 160,000 
 132,622 
2023-06-01
1.8333
11
6
 841,000 
 158,232 
2023-03-01
3.0
6
2
 7,853,213 
 75,000 
2022-06-01
0.5
1
2
 48,441 
 49,486 
2021-09-01
1.7143
12
7
 19,200,000 
 1,069,577 

Jasper Therapeutics Notable Stakeholders

A Jasper Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Jasper Therapeutics often face trade-offs trying to please all of them. Jasper Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Jasper Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ronald MartellCEO PresidentProfile
Herbert CrossCFO SecretaryProfile
Herbert CPACFO SecretaryProfile
Judith MDCoFounder DirectorProfile
Luca NotoSenior OperationsProfile
Carol ZoltowskiVP QualityProfile
Jeetinder MBAChief OfficerProfile
Wendy MDSenior MedicineProfile
Patricia CarlosSenior QualityProfile
Matthew FordVice ResourcesProfile
Edwin MDChief OfficerProfile
Susan ProhaskaCoFounder ManagementProfile
Kevin MDEx RDProfile
David MDPortfolio DevelopmentProfile

About Jasper Therapeutics Management Performance

The success or failure of an entity such as Jasper Therapeutics often depends on how effective the management is. Jasper Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Jasper management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Jasper management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.68)(0.71)
Return On Capital Employed(0.83)(0.88)
Return On Assets(0.68)(0.71)
Return On Equity(0.82)(0.78)

Jasper Therapeutics Workforce Analysis

Traditionally, organizations such as Jasper Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Jasper Therapeutics within its industry.

Jasper Therapeutics Manpower Efficiency

Return on Jasper Therapeutics Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.4M
Net Loss Per Executive4.6M
Working Capital Per Employee1.7M
Working Capital Per Executive5.5M

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.